Highlights
- Ex-Dividend Date Impact: TechnologyOne shares are down as the company trades ex-dividend today.
- 2024 Stock Performance: Despite today’s dip, TechnologyOne remains one of the year’s top-performing stocks on the ASX, with a year-to-date gain of more than 96%.
- Analyst Optimism: Leading brokers UBS and Goldman Sachs maintain bullish price targets of $33.80 and $32.69, respectively, praising the company’s SaaS-driven recurring revenue growth and resilient client base.
Shares of ASX 200 tech stock TechnologyOne (ASX:TNE) slipped nearly 1% in early trading today, trading at $30.20. The downturn comes despite no market-sensitive updates, with the company now down 17 cents per share compared to yesterday's close of $30.49.
Why the Drop?
The primary reason for today’s slight decline appears to be TechnologyOne trading ex-dividend. When a company reaches its ex-dividend date, its stock typically dips by the dividend amount, as new buyers are no longer eligible for the upcoming payout.
This predictable price adjustment aligns with standard economic theory, as the dividend value shifts from the company’s balance sheet to shareholders. TechnologyOne announced its 17.37 cents per share dividend on November 19, with payment slated for mid-December.
Broader Context
Today's dip does not overshadow the strong business performance TechnologyOne has demonstrated in 2024. The company’s Software-as-a-Service (SaaS) model has driven significant growth, with recurring revenues and pre-tax profits jumping 18% year-over-year, according to its FY24 results.
Leading brokers are optimistic about the company’s future:
- UBS: Upgraded its price target to $33.80, highlighting the robust growth in recurring revenues and sustainable profit trajectory.
- Goldman Sachs: Forecasts 20% annual pre-tax profit growth over the next five years, underpinned by TechnologyOne’s education and government clients, which are less vulnerable to economic downturns.
However, some analysts are more cautious. Barrenjoey has rated the stock a "sell," setting a target of $25.20 due to concerns over its valuation. The company’s current premium multiples are a point of contention, especially as it continues to outperform broader market benchmarks.